We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Verisk Analytics (VRSK) Beats on Q3 Earnings, Lags Revenues
Read MoreHide Full Article
Verisk Analytics, Inc. (VRSK - Free Report) reported mixed third-quarter 2018 results, with earnings beating the Zacks Consensus Estimate and revenues missing the same.
Adjusted earnings per share (EPS) of $1.08 surpassed the Zacks Consensus Estimate by a penny and improved 30.1% on a year-over-year basis. The figure was driven by strong organic growth, 2017 tax reform policy and contributions from acquisitions. However, these were partially offset by increased depreciation and amortization, interest expenses as well as higher share count.
Quarterly revenues of $598.7 million missed the consensus mark by $1.2 million but improved 9% year over year on a reported basis. Also, the figure improved 4.7% year over year on an organic constant-currency (cc) basis, partially offset by costs related to a nonrecurring project in the year-ago quarter as well as adverse weather conditions.
It seems that results could not impress investors, as the stock declined 2% in the afterhours trading. Notably, the stock has gained 30.1% in the past year compared with the industry’s rise of 10.1%.
Let’s check the numbers.
Segmental Performance
Insurance segment revenues came in at $427.7 million, up 8% year over year on a reported basis and 5.5% at organic cc.
In the segment, underwriting and rating revenues of $285.1 million was up 8.9% on a reported basis and 6.3% at organic cc. The improvement was primarily driven by strength in the company’s catastrophe modeling services and underwriting solutions. Claims revenues of $142.6 million improved 6.3% on a reported basis and 4% at organic cc. The uptick can be attributed to revenues from repair cost estimating solutions and claims analytics.
As energy business’ end market continues to improve, Energy and Specialized Markets segment revenues of $127.7 million were up 14.6% on a reported basis and 6.3% at organic cc. The improvement can also be attributed to revenues from environmental health and safety services as well as growth in consulting and research businesses.
Financial Services segment revenues of $43.3 million increased 4% on a reported basis. However, the figure declined 9.2% at organic cc, primarily owing to an impact of approximately $6 million in non-recurring project revenues in the prior-year quarter.
Verisk Analytics, Inc. Price, Consensus and EPS Surprise
Adjusted EBITDA of $284 million increased 5.4% on a reported basis and 1.6% at organic cc. Organic cc adjusted EBITDA margin was 48.5% compared with 50% in the prior-year quarter.
Adjusted EBITDA expenses (cost of revenues; selling, general and administrative expenses; investment income and others) increased 12.5% on a reported basis and 7.9% at organic cc. The upside was due to increased salaries and benefits associated with innovation and business growth of aerial imagery business.
Operating income for the third quarter was $211.1 million, up 1.3% from the prior-year quarter’s tally. Operating margin of 35.3% declined 270 basis points (bps) from the year-ago quarter’s figure.
Balance Sheet and Cash Flow
Verisk Analytics exited third-quarter 2018 with cash and cash equivalents balance of $147.6 million compared with $132 million in the last reported quarter. Long-term debt at the end of the quarter was $2.04 billion, flat sequentially.
The company generated $226.8 million of cash from operating activities and spent $55.2 million on Capex. Adjusted free cash flow was $171.6 million.
During the quarter, the company repurchased 0.9 million shares for $102 million. It also entered into a $50-million accelerated share repurchase (ASR) agreement. The shares repurchased will be delivered in the fourth quarter of 2018. As of Sep 30, 2018, the company had $584 million remaining under its share repurchase authorization.
Investors interested in the broader Business Services sector are keenly awaiting third-quarter 2018 reports from Genpact Limited (G - Free Report) , ICF International, Inc. (ICFI - Free Report) and CRA International, Inc. (CRAI - Free Report) . While ICF International and CRA International will release results on Nov 1, Genpact will announce the same on Nov 6.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Image: Bigstock
Verisk Analytics (VRSK) Beats on Q3 Earnings, Lags Revenues
Verisk Analytics, Inc. (VRSK - Free Report) reported mixed third-quarter 2018 results, with earnings beating the Zacks Consensus Estimate and revenues missing the same.
Adjusted earnings per share (EPS) of $1.08 surpassed the Zacks Consensus Estimate by a penny and improved 30.1% on a year-over-year basis. The figure was driven by strong organic growth, 2017 tax reform policy and contributions from acquisitions. However, these were partially offset by increased depreciation and amortization, interest expenses as well as higher share count.
Quarterly revenues of $598.7 million missed the consensus mark by $1.2 million but improved 9% year over year on a reported basis. Also, the figure improved 4.7% year over year on an organic constant-currency (cc) basis, partially offset by costs related to a nonrecurring project in the year-ago quarter as well as adverse weather conditions.
It seems that results could not impress investors, as the stock declined 2% in the afterhours trading. Notably, the stock has gained 30.1% in the past year compared with the industry’s rise of 10.1%.
Let’s check the numbers.
Segmental Performance
Insurance segment revenues came in at $427.7 million, up 8% year over year on a reported basis and 5.5% at organic cc.
In the segment, underwriting and rating revenues of $285.1 million was up 8.9% on a reported basis and 6.3% at organic cc. The improvement was primarily driven by strength in the company’s catastrophe modeling services and underwriting solutions. Claims revenues of $142.6 million improved 6.3% on a reported basis and 4% at organic cc. The uptick can be attributed to revenues from repair cost estimating solutions and claims analytics.
As energy business’ end market continues to improve, Energy and Specialized Markets segment revenues of $127.7 million were up 14.6% on a reported basis and 6.3% at organic cc. The improvement can also be attributed to revenues from environmental health and safety services as well as growth in consulting and research businesses.
Financial Services segment revenues of $43.3 million increased 4% on a reported basis. However, the figure declined 9.2% at organic cc, primarily owing to an impact of approximately $6 million in non-recurring project revenues in the prior-year quarter.
Verisk Analytics, Inc. Price, Consensus and EPS Surprise
Verisk Analytics, Inc. Price, Consensus and EPS Surprise | Verisk Analytics, Inc. Quote
Operating Results
Adjusted EBITDA of $284 million increased 5.4% on a reported basis and 1.6% at organic cc. Organic cc adjusted EBITDA margin was 48.5% compared with 50% in the prior-year quarter.
Adjusted EBITDA expenses (cost of revenues; selling, general and administrative expenses; investment income and others) increased 12.5% on a reported basis and 7.9% at organic cc. The upside was due to increased salaries and benefits associated with innovation and business growth of aerial imagery business.
Operating income for the third quarter was $211.1 million, up 1.3% from the prior-year quarter’s tally. Operating margin of 35.3% declined 270 basis points (bps) from the year-ago quarter’s figure.
Balance Sheet and Cash Flow
Verisk Analytics exited third-quarter 2018 with cash and cash equivalents balance of $147.6 million compared with $132 million in the last reported quarter. Long-term debt at the end of the quarter was $2.04 billion, flat sequentially.
The company generated $226.8 million of cash from operating activities and spent $55.2 million on Capex. Adjusted free cash flow was $171.6 million.
During the quarter, the company repurchased 0.9 million shares for $102 million. It also entered into a $50-million accelerated share repurchase (ASR) agreement. The shares repurchased will be delivered in the fourth quarter of 2018. As of Sep 30, 2018, the company had $584 million remaining under its share repurchase authorization.
Zacks Rank & Upcoming Releases
Verisk Analytics currently has a Zacks Rank #4 (Sell). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Investors interested in the broader Business Services sector are keenly awaiting third-quarter 2018 reports from Genpact Limited (G - Free Report) , ICF International, Inc. (ICFI - Free Report) and CRA International, Inc. (CRAI - Free Report) . While ICF International and CRA International will release results on Nov 1, Genpact will announce the same on Nov 6.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>